Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 17, 2010
- Accepted for publication April 20, 2010
- Published online August 2, 2010.
Article Versions
- previous version (July 21, 2010 - 13:45).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2010 by Society of Nuclear Medicine
Author Information
- Ugo De Giorgi1–3,
- Michal Mego1,2,
- Eric M. Rohren4,
- Ping Liu5,
- Beverly C. Handy6,
- James M. Reuben2,
- Homer A. Macapinlac4,
- Gabriel N. Hortobagyi1,
- Massimo Cristofanilli1 and
- Naoto T. Ueno1,7
- 1Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 3Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
- 4Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 5Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 6Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
- For correspondence or reprints contact: Naoto T. Ueno, Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. E-mail: nueno{at}mdanderson.org
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
- Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer
- Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer: 18F-FDG PET/CT Study
- Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment
- Microtube Device for Selectin-Mediated Capture of Viable Circulating Tumor Cells from Blood
- 18F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer
- Circulating Tumor Cells and PET